APPARATUS AND METHOD FOR BAKING GLASS SUBSTRATE
    23.
    发明申请
    APPARATUS AND METHOD FOR BAKING GLASS SUBSTRATE 有权
    烘烤玻璃基材的装置及方法

    公开(公告)号:US20140007620A1

    公开(公告)日:2014-01-09

    申请号:US13641664

    申请日:2012-08-02

    CPC classification number: C03B32/00 C03C17/001 C03C17/32 C03C2218/31

    Abstract: The present invention discloses an apparatus for baking a glass substrate, which includes: a baking oven, a support component, a temperature sensing device, a heating device, a cooling device, and a temperature controlling device. The present invention further discloses a method for baking a glass substrate. The present invention is capable of dynamically controlling the temperature of the support component, which contacts the glass substrate. The temperature of the glass substrate keeps identical and the temperature of the support component keep identical, so as to prevent a Mura defect appearing on the glass substrate.

    Abstract translation: 本发明公开了一种玻璃基板的烘烤装置,其特征在于,包括:烘烤炉,支撑部件,温度检测装置,加热装置,冷却装置以及温度控制装置。 本发明还公开了一种烘烤玻璃基板的方法。 本发明能够动态地控制与玻璃基板接触的支撑部件的温度。 玻璃基板的温度保持相同,并且支撑部件的温度保持相同,从而防止出现在玻璃基板上的Mura缺陷。

    Method and device for recording media
    24.
    发明授权
    Method and device for recording media 有权
    记录介质的方法和装置

    公开(公告)号:US08438167B2

    公开(公告)日:2013-05-07

    申请号:US13173696

    申请日:2011-06-30

    Applicant: Tao Ma

    Inventor: Tao Ma

    CPC classification number: G11B27/309

    Abstract: A method and a device for recording media are provided. The method includes performing a media recording process. During the media recording process, periodically media index information are generated according to currently written media chunks. The generated media index information is saved.

    Abstract translation: 提供了一种用于记录介质的方法和装置。 该方法包括执行媒体记录处理。 在媒体记录过程期间,根据当前书写的媒体块生成周期性媒体索引信息。 生成的媒体索引信息被保存。

    Upper-bearing movable formwork for constructing continuous box girder for bridge superstructure
    25.
    发明授权
    Upper-bearing movable formwork for constructing continuous box girder for bridge superstructure 有权
    用于桥梁上部结构构造连续箱梁的上轴承活动模板

    公开(公告)号:US08387941B2

    公开(公告)日:2013-03-05

    申请号:US13057347

    申请日:2009-07-30

    CPC classification number: E01D21/00

    Abstract: An upper-bearing typed movable formwork used for cast-in-situ of concrete box girder in bridge engineering, comprising left and right legs (7) which are respectively fixed on a pier, left and right longitudinal/transverse sliding mechanisms (9), bearing devices and a template system. The left and right longitudinal/transverse sliding mechanisms (9) are respectively arranged on the left and right legs (7) and can move horizontally along the left and right legs (7), the bearing devices are respectively fixed on the left and right longitudinal/transverse sliding mechanisms (9), the template system comprises a bottom formwork (6), an internal formwork (3), a left formwork and a right formwork, the bottom formwork (6) is formed by screw connection of a left bottom formwork and a right bottom formwork (6a,6b) which are symmetrical about the axis line of the concrete box girder, two ends of the bottom formwork are respectively fixed on two opposite internal side surfaces of the left main beam and the right main beam (1). The movable formwork also comprises a plurality of adjustable supporting rods (14) used for supporting the template system.

    Abstract translation: 一种用于桥梁工程中混凝土箱梁原位浇筑的上轴承型可移动模板,包括分别固定在墩,左右纵向/横向滑动机构(9)上的左腿和右腿(7) 轴承装置和模板系统。 左右纵向/横向滑动机构(9)分别布置在左腿和右腿(7)上,并可沿左右腿(7)水平移动,轴承装置分别固定在左右纵向 /横向滑动机构(9),模板系统包括底部模板(6),内部模板(3),左模板和右模板,底模板(6)由左底模板 和围绕混凝土箱梁的轴线对称的右底模板(6a,6b),底模板的两端分别固定在左主梁和右主梁(1)的两个相对的内侧表面上 )。 可移动模板还包括用于支撑模板系统的多个可调支撑杆(14)。

    GLUCAGON ANTAGONIST-GIP AGONIST CONJUGATES AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISORDERS AND OBESITY
    26.
    发明申请
    GLUCAGON ANTAGONIST-GIP AGONIST CONJUGATES AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISORDERS AND OBESITY 有权
    GLUCAGON ANTAGONIST-GIP激动剂联合用药和组合物治疗代谢障碍和肥胖

    公开(公告)号:US20120322725A1

    公开(公告)日:2012-12-20

    申请号:US13575363

    申请日:2011-01-26

    CPC classification number: C07K14/605 A61K38/26 A61K2300/00

    Abstract: Provided herein are peptide combinations comprising a GIP agonist peptide and a glucagon antagonist peptide. In some embodiments, the peptide combination is provided as a composition, e.g., a pharmaceutical composition, while in other embodiments, the peptide combination is provided as a kit. In yet other embodiments, the peptide combination is provided as a conjugate, e.g., a fusion peptide, a heterodimer. In specific aspects, the GIP agonist peptide is an analog of native human glucagon. In specific aspects, the glucagon antagonist peptide is an analog of native human glucagon. In some embodiments, the GIP agonist peptide is covalently attached to the glucagon antagonist peptide via a linker. Methods of treating a disease, e.g., a metabolic disorder, such as diabetes and obesity, comprising administering the peptide compositions described herein are further provided.

    Abstract translation: 本文提供了包含GIP激动剂肽和胰高血糖素拮抗肽的肽组合。 在一些实施方案中,肽组合作为组合物例如药物组合物提供,而在其它实施方案中,肽组合作为试剂盒提供。 在其它实施方案中,肽组合作为缀合物提供,例如融合肽,异二聚体。 在具体方面,GIP激动剂肽是天然人胰高血糖素的类似物。 在具体方面,胰高血糖素拮抗剂肽是天然人胰高血糖素的类似物。 在一些实施方案中,GIP激动剂肽通过接头共价连接到胰高血糖素拮抗剂肽。 进一步提供治疗疾病例如代谢紊乱(例如糖尿病和肥胖症)的方法,其包括施用本文所述的肽组合物。

    METHOD AND SYSTEM FOR CONTROLLING SAFE TAKEOFF AND LANDING OF PILOTLESS VERTICAL TAKEOFF AND LANDING (VTOL) AIRCRAFT

    公开(公告)号:US20230273625A1

    公开(公告)日:2023-08-31

    申请号:US18144246

    申请日:2023-05-08

    Applicant: Tao Ma

    Inventor: Tao Ma

    Abstract: In one aspect, a system for performing a pre-takeoff passenger safety procedure for a pilotless vertical takeoff and landing (VTOL) aircraft is disclosed. The system can begin by receiving authentication information from each of one or more passengers attempting to enter a passenger cabin of the VTOL. The system then authenticates each of the one or more passengers as an authorized passenger based on the authentication information. If the one or more passengers are successfully authenticated, the system allows the one or more passengers to enter the passenger cabin of the VTOL aircraft, and subsequently performs a set of onboard pre-takeoff checks to determine if the VTOL aircraft and the one or more passengers are safe for takeoff. In response to determining that the VTOL aircraft and the one or more passengers are safe for takeoff, the system further confirms readiness of each of the passengers for immediate takeoff.

    Session initiation protocol adapter system and method providing stateless node mapping to a stateful server node hosting a communication session for an actor
    29.
    发明授权
    Session initiation protocol adapter system and method providing stateless node mapping to a stateful server node hosting a communication session for an actor 有权
    会话发起协议适配器系统和方法提供无状态节点映射到承载用于演员的通信会话的状态服务器节点

    公开(公告)号:US09258379B2

    公开(公告)日:2016-02-09

    申请号:US13339300

    申请日:2011-12-28

    CPC classification number: H04L67/2809

    Abstract: In accordance with various embodiments, a set of features are described for enabling an application server platform for telecom based applications. A system for providing an application server for telecom-based applications can include an application server that includes a session initiation protocol (SIP) adapter. The SIP adapter can use a connection oriented protocol and provides interactions with application code in an actor of said application server by means of asynchronized SIP protocol events. The SIP adapter can also provide stateless node mapping to a stateful server node hosting a specific session for the actor.

    Abstract translation: 根据各种实施例,描述了一组功能,用于启用用于基于电信的应用的应用服务器平台。 用于为基于电信的应用提供应用服务器的系统可以包括包括会话发起协议(SIP)适配器的应用服务器。 SIP适配器可以使用面向连接的协议,并且通过异步SIP协议事件提供与所述应用服务器的演员中的应用代码的交互。 SIP适配器还可以向托管运行者的特定会话的状态服务器节点提供无状态节点映射。

    Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
    30.
    发明授权
    Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity 有权
    胰岛素拮抗剂-GIP激动剂缀合物和用于治疗代谢紊乱和肥胖症的组合物

    公开(公告)号:US08551946B2

    公开(公告)日:2013-10-08

    申请号:US13575363

    申请日:2011-01-26

    CPC classification number: C07K14/605 A61K38/26 A61K2300/00

    Abstract: Provided herein are peptide combinations comprising a GIP agonist peptide and a glucagon antagonist peptide. In some embodiments, the peptide combination is provided as a composition, e.g., a pharmaceutical composition, while in other embodiments, the peptide combination is provided as a kit. In yet other embodiments, the peptide combination is provided as a conjugate, e.g., a fusion peptide, a heterodimer. In specific aspects, the GIP agonist peptide is an analog of native human glucagon. In specific aspects, the glucagon antagonist peptide is an analog of native human glucagon. In some embodiments, the GIP agonist peptide is covalently attached to the glucagon antagonist peptide via a linker. Methods of treating a disease, e.g., a metabolic disorder, such as diabetes and obesity, comprising administering the peptide compositions described herein are further provided.

    Abstract translation: 本文提供了包含GIP激动剂肽和胰高血糖素拮抗肽的肽组合。 在一些实施方案中,肽组合作为组合物例如药物组合物提供,而在其它实施方案中,肽组合作为试剂盒提供。 在其它实施方案中,肽组合作为缀合物提供,例如融合肽,异二聚体。 在具体方面,GIP激动剂肽是天然人胰高血糖素的类似物。 在具体方面,胰高血糖素拮抗剂肽是天然人胰高血糖素的类似物。 在一些实施方案中,GIP激动剂肽通过接头共价连接到胰高血糖素拮抗剂肽。 进一步提供治疗疾病例如代谢紊乱(例如糖尿病和肥胖症)的方法,包括施用本文所述的肽组合物。

Patent Agency Ranking